This webinar highlights the needs and versatility of ultrahigh-resolution mass spectrometers for heightened mAb characterization in Pfizer’s MSBC lab, as well as addresses the importance of different separation techniques coupled to Mass Spectrometry. Following an introduction to Pfizer’s biotherapeutic heightened characterization strategy, discussions will be focused on in-depth understanding of biotherapeutics at the subunit level and hotspot characterization at the peptide level.
Run time: 31:48 mins
ultrahigh-resolution mass spectrometers for heightened mAb characterization
Video Credit: Bruker Life Sciences Mass Spectrometry